RETRACTED ARTICLE: Examination of the effects of microRNA-145-5p and phosphoserine aminotransferase 1 in colon cancer
Authors:
Open Access
- 2 May 2022
- journal article
- retracted article
- Published by Taylor & Francis in Bioengineered
- Vol. 13 (5) , 12794-12806
Abstract
Previous studies manifested that microRNA-145-5p is pivotal in the development of various cancers. Nevertheless, the potential function of microRNA-145-5p in colorectal cancer remains unclear. This study attempted to investigate the potential role and possible mechanism of microRNA-145-5p in colon cancer. MicroRNA-145-5p and phosphoserine aminotransferase 1 (PSAT1) levels in colon cancer cells were assayed via quantitative reverse transcription polymerase chain reaction (qRT-PCR). Cell proliferation and cell cycle status were assessed using Cell Counting Kit-8, colony formation, and flow cytometry. The target binding relationship of microRNA-145-5p and PSAT1 was identified using bioinformatics analysis and dual-luciferase reporter gene assay. The result of qRT-PCR disclosed that microRNA-145-5p was markedly down-regulated and PSAT1 level was up-regulated in colon cancer cell lines. Besides, enforced microRNA-145-5p level repressed proliferation of colon cancer cells, and cells were arrested in G0-G1 phase. Bioinformatics analysis and dual-luciferase reporter genes confirmed that PSAT1 was a downstream target of microRNA-145-5p. Enforced PSAT1 level remarkably modulated cell cycle and fostered cell proliferation. Furthermore, rescue experiments displayed that microRNA-145-5p restrained cell cycle progression and cell proliferation and forced PSAT1 level could partially reverse this process. Taken together, our findings demonstrated that microRNA-145-5p repressed colon cancer cell cycle progression and cell proliferation via targeting PSAT1. Our findings identified microRNA-145-5p as an essential tumor repressor gene in colon cancer and may provide a novel biomarker for colon cancer. Graphical abstractKeywords
Funding Information
- associated with the work featured in this
This publication has 39 references indexed in Scilit:
- Diet and colorectal cancerMaturitas, 2015
- PSAT1 regulates cyclin D1 degradation and sustains proliferation of non‐small cell lung cancer cellsInternational Journal of Cancer, 2014
- MicroRNAs in cancer: biomarkers, functions and therapyTrends in Molecular Medicine, 2014
- Serine, but Not Glycine, Supports One-Carbon Metabolism and Proliferation of Cancer CellsCell Reports, 2014
- Growth of the pancreatic cancer cell line PANC-1 is inhibited by protein phosphatase 2A inhibitors through overactivation of the c-Jun N-terminal kinase pathwayEuropean Journal of Cancer, 2011
- Functional genomics reveal that the serine synthesis pathway is essential in breast cancerNature, 2011
- Vascular Endothelial Growth Factor C as a Predictor of Early Recurrence and Poor Prognosis of Resected Stage I Non-small Cell Lung CancerAnnals of the Academy of Medicine, Singapore, 2011
- Overexpression of phosphoserine aminotransferase PSAT1 stimulates cell growth and increases chemoresistance of colon cancer cellsMolecular Cancer, 2008
- Characterization of human phosphoserine aminotransferase involved in the phosphorylated pathway of l-serine biosynthesisBiochemical Journal, 2003
- Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT MethodMethods, 2001